Benin Management’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$47.3K Hold
19,000
– – 0.01% 150
2026
Q2
$51.1K Hold
19,000
– – 0.01% 150
2026
Q1
$42.2K Hold
19,000
– – 0.01% 145
2025
Q4
$31K Buy
+19,000
New +$29.3K 0.01% 138

Other funds holding OVID

Benin Management's OVID Position: Q3 2026 in Review

Benin Management held its Ovid Therapeutics (OVID) position steady in Q3 2026 at 19,000 shares worth $47.3K. The position accounts for 0.01% of the portfolio, ranked #150.

Benin Management first reported a position in OVID in Q4 2025 and has held it in 4 quarters since. The position peaked at $51.1K in Q2 2026. 81 funds tracked by Wall St. Rank hold OVID as of Q3 2026.

  • Benin Management held 19,000 shares of Ovid Therapeutics worth $47.3K as of Q3 2026.
  • Benin Management left its Ovid Therapeutics share count unchanged in Q3 2026.
  • Ovid Therapeutics made up 0.01% of Benin Management's portfolio in Q3 2026, its #150 holding.
  • Benin Management first reported a position in Ovid Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Benin Management's Ovid Therapeutics position peaked at $51.1K in Q2 2026.
  • 81 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q3 2026.

Based on Benin Management's 13F filing for Q3 2026, filed 22 Oct 2026.